Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-05-04 Sale |
2020-05-06 9:31 pm |
STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer |
272 | $11.51 | $3,131 | 197,658 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-06-10 Equity Swap |
2020-06-10 11:22 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer |
327,878 | $0 | 0 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-10 11:22 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer |
45,000 | $0 | 0 (Direct) |
View |
| 2020-06-10 Equity Swap |
2020-06-10 11:22 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Sard Mark Director |
51,468 | $0 | 0 (Direct) |
View |
| 2020-06-10 Equity Swap |
2020-06-10 11:21 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | HUME DANIEL Director |
35,468 | $0 | 0 (Direct) |
View |
| 2020-06-10 Equity Swap |
2020-06-10 11:20 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Bergstein Ivan Chief Executive Officer |
3,024,336 | $0 | 0 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-10 11:20 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Bergstein Ivan Chief Executive Officer |
220,000 | $0 | 0 (Direct) |
View |
| 2020-06-10 Equity Swap |
2020-06-10 11:19 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | BENTSUR RON Director |
66,346 | $0 | 0 (Direct) |
View |
| 2020-06-10 Equity Swap |
2020-06-10 11:18 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer |
1,374,352 | $0 | 0 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-10 11:18 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer |
600,000 | $0 | 0 (Direct) |
View |
| 2020-06-10 Equity Swap |
2020-06-10 11:17 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer |
200,891 | $0 | 0 (Direct) |
View |
| 2020-06-10 Equity Swap |
2020-06-10 11:15 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Cline Darren S Director |
35,468 | $0 | 0 (Direct) |
View |
| 2020-06-10 Equity Swap |
2020-06-10 11:12 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Forman Alan S Director |
88,298 | $0 | 0 (Direct) |
View |
| 2020-06-10 Equity Swap |
2020-06-10 11:11 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | ZUERBLIS KENNETH J Director |
60,121 | $0 | 0 (Direct) |
View |